BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 10828869)

  • 1. Introduction of the oncological pediatric risk of mortality score (O-PRISM) for ICU support following stem cell transplantation in children.
    Schneider DT; Lemburg P; Sprock I; Heying R; Göbel U; Nürnberger W
    Bone Marrow Transplant; 2000 May; 25(10):1079-86. PubMed ID: 10828869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in children requiring admission to an intensive care unit after hematopoietic stem cell transplant.
    Cheuk DK; Ha SY; Lee SL; Chan GC; Tsoi NS; Lau YL
    Hematol Oncol; 2004 Mar; 22(1):1-9. PubMed ID: 15152366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial evaluation of the oncological pediatric risk of mortality (O-PRISM) score following allogeneic bone marrow transplantation in children.
    Schneider DT; Cho J; Laws HJ; Dilloo D; Göbel U; Nürnberger W
    Bone Marrow Transplant; 2002 Mar; 29(5):383-9. PubMed ID: 11919727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation.
    Diaz MA; Vicent MG; Prudencio M; Rodriguez F; Marin C; Serrano A; Sevilla J; Casado J; Madero L
    Haematologica; 2002 Mar; 87(3):292-8. PubMed ID: 11869942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports.
    Pène F; Aubron C; Azoulay E; Blot F; Thiéry G; Raynard B; Schlemmer B; Nitenberg G; Buzyn A; Arnaud P; Socié G; Mira JP
    J Clin Oncol; 2006 Feb; 24(4):643-9. PubMed ID: 16380411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
    Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of children requiring admission to an intensive care unit after bone marrow transplantation.
    Jacobe SJ; Hassan A; Veys P; Mok Q
    Crit Care Med; 2003 May; 31(5):1299-305. PubMed ID: 12771594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
    Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
    Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sepsis-related Organ Failure Assessment (SOFA) score is predictive for survival of patients admitted to the intensive care unit following allogeneic blood stem cell transplantation.
    Neumann F; Lobitz O; Fenk R; Bruns I; Köstering M; Steiner S; Hennersdorf M; Kelm M; Strauer BE; Germing U; Hinke A; Haas R; Kobbe G
    Ann Hematol; 2008 Apr; 87(4):299-304. PubMed ID: 18219487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing outcomes for children requiring intensive care following hematopoietic stem cell transplantation.
    Kache S; Weiss IK; Moore TB
    Pediatr Transplant; 2006 May; 10(3):299-303. PubMed ID: 16677352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the intensive care unit in children undergoing bone marrow transplantation with life-threatening complications.
    Díaz de Heredia C; Moreno A; Olivé T; Iglesias J; Ortega JJ
    Bone Marrow Transplant; 1999 Jul; 24(2):163-8. PubMed ID: 10455344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early elevation of C-reactive protein correlates with severe infection and nonrelapse mortality in children undergoing allogeneic stem cell transplantation.
    McNeer JL; Kletzel M; Rademaker A; Alford K; O'Day K; Schaefer C; Duerst R; Jacobsohn DA
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):350-7. PubMed ID: 20005964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors.
    Jackson SR; Tweeddale MG; Barnett MJ; Spinelli JJ; Sutherland HJ; Reece DE; Klingemann HG; Nantel SH; Fung HC; Toze CL; Phillips GL; Shepherd JD
    Bone Marrow Transplant; 1998 Apr; 21(7):697-704. PubMed ID: 9578310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of acute physiology and chronic health evaluation (APACHE) II and III score-based screening in patients receiving allogeneic hematopoietic stem-cell transplantation.
    Kim SW; Kami M; Urahama N; Yamamoto R; Hori A; Imataki O; Kanda Y; Tanosaki R; Mineishi S; Takaue Y; Honda O
    Transplantation; 2003 Feb; 75(4):566-70. PubMed ID: 12605131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival in a recent cohort of mechanically ventilated pediatric allogeneic hematopoietic stem cell transplantation recipients.
    van Gestel JP; Bollen CW; Bierings MB; Boelens JJ; Wulffraat NM; van Vught AJ
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1385-93. PubMed ID: 19041061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, predisposing factors, and outcome of engraftment syndrome in pediatric allogeneic stem cell transplant recipients.
    Schmid I; Stachel D; Pagel P; Albert MH
    Biol Blood Marrow Transplant; 2008 Apr; 14(4):438-44. PubMed ID: 18342786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
    Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
    Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients.
    Afessa B; Tefferi A; Dunn WF; Litzow MR; Peters SG
    Crit Care Med; 2003 Jun; 31(6):1715-21. PubMed ID: 12794410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing allo-RIC.
    Barba P; Piñana JL; Martino R; Valcárcel D; Amorós A; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):413-20. PubMed ID: 19922807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.